Use of global assessment measures in dementia drug trials

K Rockwood

doi:10.1016/0895-4356(94)90039-6

Use of global assessment measures in dementia drug trials

J Clin Epidemiol. 1994 Jan;47(1):101-3. doi: 10.1016/0895-4356(94)90039-6.

Author

K Rockwood¹

Affiliation

¹ Division of Geriatric Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

PMID: 8283190
DOI: 10.1016/0895-4356(94)90039-6

Abstract

I argue in this paper that the use of a global clinical impression of change as a primary measure in dementia drug trials is appropriate, given that we do not yet understand clearly enough what Alzheimer's disease looks like as it gets better.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Alzheimer Disease / drug therapy*
Clinical Trials as Topic / methods*
Humans
Treatment Outcome